154 related articles for article (PubMed ID: 35910116)
1. Newly Synthesized Pyrazolinone Chalcones as Anticancer Agents via Inhibiting the PI3K/Akt/ERK1/2 Signaling Pathway.
Noser AA; Shehadi IA; Abdelmonsef AH; Salem MM
ACS Omega; 2022 Jul; 7(29):25265-25277. PubMed ID: 35910116
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and molecular docking of novel substituted azepines as inhibitors of PI3K/Akt/TSC2/mTOR signaling pathway in colorectal carcinoma.
Noser AA; Abdelmonsef AH; Salem MM
Bioorg Chem; 2023 Feb; 131():106299. PubMed ID: 36493622
[TBL] [Abstract][Full Text] [Related]
3. New Amino Acid Schiff Bases as Anticancer Agents via Potential Mitochondrial Complex I-Associated Hexokinase Inhibition and Targeting AMP-Protein Kinases/mTOR Signaling Pathway.
Noser AA; Abdelmonsef AH; El-Naggar M; Salem MM
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500765
[TBL] [Abstract][Full Text] [Related]
4. Altersolanol B, a fungal tetrahydroanthraquinone, inhibits the proliferation of estrogen receptor-expressing (ER+) human breast adenocarcinoma by modulating PI3K/AKT, p38/ERK MAPK and associated signaling pathways.
Siraj MA; Jacobs AT; Tan GT
Chem Biol Interact; 2022 May; 359():109916. PubMed ID: 35346647
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone-Thienopyrimidine Derivatives in HepG2 and MCF-7 Cell Lines.
Safwat GM; Hassanin KMA; Mohammed ET; Ahmed EK; Abdel Rheim MR; Ameen MA; Abdel-Aziz M; Gouda AM; Peluso I; Almeer R; Abdel-Daim MM; Abdel-Wahab A
Oxid Med Cell Longev; 2021; 2021():4759821. PubMed ID: 35003514
[TBL] [Abstract][Full Text] [Related]
6. Lappaconitine sulfate induces apoptosis and G0/G1 phase cell cycle arrest by PI3K/AKT signaling pathway in human non-small cell lung cancer A549 cells.
Qu D; Ma J; Song N; Hui L; Yang L; Guo Y; Sang C
Acta Histochem; 2020 Jul; 122(5):151557. PubMed ID: 32622431
[TBL] [Abstract][Full Text] [Related]
7. Novel 4-aminoquinazoline derivatives induce growth inhibition, cell cycle arrest and apoptosis via PI3Kα inhibition.
Fan YH; Ding HW; Liu DD; Song HR; Xu YN; Wang J
Bioorg Med Chem; 2018 May; 26(8):1675-1685. PubMed ID: 29475582
[TBL] [Abstract][Full Text] [Related]
8. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
Li KW; Wang SH; Wei X; Hou YZ; Li ZH
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
[TBL] [Abstract][Full Text] [Related]
10. In vitro antiproliferative activity of 2,3-dihydroxy-9,10-anthraquinone induced apoptosis against COLO320 cells through cytochrome c release caspase mediated pathway with PI3K/AKT and COX-2 inhibition.
Balachandran C; Emi N; Arun Y; Yamamoto N; Duraipandiyan V; Inaguma Y; Okamoto A; Ignacimuthu S; Al-Dhabi NA; Perumal PT
Chem Biol Interact; 2016 Apr; 249():23-35. PubMed ID: 26915975
[TBL] [Abstract][Full Text] [Related]
11. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
[TBL] [Abstract][Full Text] [Related]
12. CB-RAF600E-1 exerts efficacy in vemurafenib-resistant and non-resistant-melanoma cells via dual inhibition of RAS/RAF/MEK/ERK and PI3K/Akt signaling pathways.
Al Shahrani M; Rajagopalan P; Abohassan M; Alshahrani M; Alraey Y
Saudi J Biol Sci; 2022 Jun; 29(6):103285. PubMed ID: 35592740
[TBL] [Abstract][Full Text] [Related]
13. 3-Arylamino-quinoxaline-2-carboxamides inhibit the PI3K/Akt/mTOR signaling pathways to activate P53 and induce apoptosis.
Chen NY; Lu K; Yuan JM; Li XJ; Gu ZY; Pan CX; Mo DL; Su GF
Bioorg Chem; 2021 Sep; 114():105101. PubMed ID: 34175723
[TBL] [Abstract][Full Text] [Related]
14. New 1,3,4-thiadiazoles as potential anticancer agents: pro-apoptotic, cell cycle arrest, molecular modelling, and ADMET profile.
Hekal MH; Farag PS; Hemdan MM; El-Sayed AA; Hassaballah AI; El-Sayed WM
RSC Adv; 2023 May; 13(23):15810-15825. PubMed ID: 37250214
[TBL] [Abstract][Full Text] [Related]
15. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
16. The integrative bioinformatics approaches to predict the xanthohumol as anti-breast cancer molecule: Targeting cancer cells signaling PI3K and AKT kinase pathway.
Gupta KK; Sharma KK; Chandra H; Panwar H; Bhardwaj N; Altwaijry NA; Alsfouk AA; Dlamini Z; Afzal O; Altamimi ASA; Khan S; Mishra AP
Front Oncol; 2022; 12():950835. PubMed ID: 36591523
[TBL] [Abstract][Full Text] [Related]
17. Molecular docking, anti-proliferative activity and induction of apoptosis in human liver cancer cells treated with androstane derivatives: Implication of PI3K/AKT/mTOR pathway.
Kattan SW; Nafie MS; Elmgeed GA; Alelwani W; Badar M; Tantawy MA
J Steroid Biochem Mol Biol; 2020 Apr; 198():105604. PubMed ID: 31982513
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Anticancer Activity on Prostate Cancer Cell Lines and Molecular Modeling Studies of Flurbiprofen-Thioether Derivatives as Potential Target of MetAP (Type II).
Yılmaz Ö; Bayer B; Bekçi H; Uba AI; Cumaoğlu A; Yelekçi K; Küçükgüzel ŞG
Med Chem; 2020; 16(6):735-749. PubMed ID: 31203805
[TBL] [Abstract][Full Text] [Related]
19. Carvacrol Promotes Cell Cycle Arrest and Apoptosis through PI3K/AKT Signaling Pathway in MCF-7 Breast Cancer Cells.
Mari A; Mani G; Nagabhishek SN; Balaraman G; Subramanian N; Mirza FB; Sundaram J; Thiruvengadam D
Chin J Integr Med; 2021 Sep; 27(9):680-687. PubMed ID: 32572774
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of anilide (dicarboxylic acid) shikonin esters as antitumor agents through targeting PI3K/Akt/mTOR signaling pathway.
Ma Y; Yang X; Han H; Wen Z; Yang M; Zhang Y; Fu J; Wang X; Yin T; Lu G; Qi J; Lin H; Wang X; Yang Y
Bioorg Chem; 2021 Jun; 111():104872. PubMed ID: 33838560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
